Roquefort Therapeutics plc
Biotechnology Research • 
London, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | London, England, United Kingdom |
| Phone number | +4428082025 |
| Website | |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
Key Contact at Roquefort Therapeutics plc
Stephen West
Chairman & Founder
About Roquefort Therapeutics plc
Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or selling to big pharma. Since listing in March 2021, Roquefort Therapeutics has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines. Roquefort Therapeutics’ portfolio consists of four fully funded, novel patent-protected pre-clinical anti-cancer medicines. The highly complementary profile of four best-in-class medicines consists of: 1. Midkine antibodies with significant in vivo efficacy and toxicology studies; 2. Midkine RNA therapeutics with novel anti-cancer gene editing action; 3. MK cell therapy with direct and NK-mediated anti-cancer action; and 4. siRNA targeting novel STAT-6 target in solid tumours showing significant in vivo efficacy.
Roquefort Therapeutics plc revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Roquefort Therapeutics plc has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Roquefort Therapeutics plc has never raised funding before.
Roquefort Therapeutics plc Tech Stack
Discover the technologies and tools that power Roquefort Therapeutics plc's digital infrastructure, from frameworks to analytics platforms.
Web servers
PaaS
JavaScript libraries
Programming languages
Font scripts
CMS
Video players
SSL/TLS certificate authorities
CDN
Font scripts
Spain
France
United States
Netherlands
AustraliaFrequently asked questions
4.8
40,000 users
